Delivery Order SPE2DB22D9367-SPE2DB24FSV49
Award Date 12/21/23
Potential Completion Date 1/16/24
Potential Value $8.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $10,720.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,566,777,703 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products and medical supplies for the Department of...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,568,201,766 units of the contraceptive implant Nexplanon. The $5,554.48 order has a completion date of May 30, 2025 and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products to military health facilities worldwide. This IDC, which...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $12,864.42 to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,257,903 units of the contraceptive implant NEXPLANON 68 MG by May 1, 2024. This delivery order is part of a larger five-year indefinite delivery, indefinite quantity (IDIQ) contract, SPE2DB24D9238|SPE2DB24FDQDS, valued at up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $17,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 68 mg NEXPLANON contraceptive implants. This delivery order falls under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has no...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,728.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,565,176,099 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows the DLA to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,144.07 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,564,040,081 units of the contraceptive implant NEXPLANON 68 MG. This award is part of a larger Indefinite Delivery Vehicle (IDV) contract, SPE2DB24FB3JV, held by DMS Pharmaceutical Group with DLA, valued up to $4,999,999 through 2025, to provide a broad range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,564,134,203 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This order was placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, valued at up to $4,999,999 through 2025. The DLA utilizes this vehicle to issue delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,568,723,895 units of the contraceptive implant NEXPLANON 68 MG. The contract, valued at $8,331.72, has an ultimate completion date of July 23, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS with a potential value of $6,837.40. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products, including specialized contraceptive items, in support of military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,033.44 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,557,298,149 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which covers a wide range of branded and generic...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB24FSV49Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,181,463 units of the contraceptive implant NEXPLANON 68 MG. The $8,204.88 delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. to supply pharmaceuticals and medical products to DLA Troop Support Medical facilities worldwide. The contract does not have a set-aside designation and has a potential value up to $5 million through December 2025.
Generated 3/21/24, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 12/21/23 |